Editorial Commentary

Abstract

No AccessUrology PracticePatient Care1 Jul 2015Editorial Commentary Ranjith Ramasamy, Jason M. Scovell, and Larry I. Lipshultz Ranjith RamasamyRanjith Ramasamy More articles by this author , Jason M. ScovellJason M. Scovell More articles by this author , and Larry I. LipshultzLarry I. Lipshultz More articles by this author View All Author Informationhttps://doi.org/10.1016/j.urpr.2014.10.021AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Commentary." Urology Practice, 2(4), pp. 204–205 References 1 : The use of clomiphene citrate in male infertility. J Urol1984; 131: 425. Link, Google Scholar 2 : Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol2006; 176: 1307. Link, Google Scholar 3 : WITHDRAWN: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev1996; : CD000151. Google Scholar 4 : Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertil Steril2014; 102: 720. Google Scholar © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 2Issue 4July 2015Page: 204-205 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ranjith Ramasamy More articles by this author Jason M. Scovell More articles by this author Larry I. Lipshultz More articles by this author Expand All Advertisement PDF downloadLoading ...